According to FT, The 5 analysts offering 12 month price targets for Abcam Plc have a median target of 660.00, with a high estimate of 850.00 and a low estimate of 581.00.
Advertisement
Several executives took part in recent insider activity for the stock. The peak price level was also seen at $89.71 while the days lowest was $88.47. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. It closed at $88.95, notching a gain of 1.19% for the day. The institutional ownership stake in the corporation is 78.70% while the Beta value stands at 1.13.
A number of Reuters analysts recently commented on the stock. Hitchwood Capital Management LP bought a new position in AmerisourceBergen Corp. during the fourth quarter worth approximately $217,791,000. Burgundy Asset Management Ltd. increased its position in AmerisourceBergen Corp.by 46.0% in the first quarter. The insider owns 387,954 shares as of Aug 5, 2016, now worth $34508508. AmerisourceBergen Corp. has a 52 week low of $73.31 and a 52 week high of $108.18. The company has a market cap of $18.86 billion.
The company’s 50 day moving average is 83.67 and its 200 day moving average is 83.62.
According to a report issued to investors by Mizuho Securities on Thursday, shares of AmerisourceBergen (NYSE:ABC) had their rating reiterated by analysts to “Neutral”. Analysts had estimated an EPS of $1.27. During the same period previous year, the company earned $1.20 EPS. The company had revenue of $36900.00 million for the quarter, compared to analysts expectations of $36705.18 million. On 2016-11-03, AmerisourceBergen Corporation (Holding Co) will issue a report on its next quarter earnings and on 2016-11-03, it will have its earnings for the next fiscal year released. Equities research analysts anticipate that AmerisourceBergen Corp. will post $5.56 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 6th. Stockholders of record on Monday, August 22nd will be given a dividend of $0.34 per share.
A number of Wall Street analysts stated their opinion on the stock. Zacks Investment Research upgraded shares of AmerisourceBergen Corp. from a “sell” rating to a “hold” rating in a research report on Monday, May 2nd. AmerisourceBergen Corporation (Holding Co) got Downgrade on 5-May-16 where investment firm Avondale Downgrade the stock from Mkt Outperform to Mkt Perform. Analyst expected twelve month price target of $92.82. Citigroup Inc. increased their price objective on shares of AmerisourceBergen Corp. from $100.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, August 3rd. Eleven research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The price target estimates represents a standard deviation of 7.32.
Advertisement
In the liquidity ratio analysis; AmerisourceBergen Corporation’s (ABC) debt to equity ratio was 2.35 while current ratio was 0.90. The Firm operates through two divisions: Pharmaceutical Distribution and Other. The Firm also provides data and other services to its manufacturing customers. It distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers.
